132 related articles for article (PubMed ID: 31343409)
1. FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding.
Hu W; Zhang Y; Sun X; Zhang T; Xu L; Xie H; Li Z; Liu W; Lou J; Chen W
Elife; 2019 Jul; 8():. PubMed ID: 31343409
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane domain dependent inhibitory function of FcγRIIB.
Wang J; Li Z; Xu L; Yang H; Liu W
Protein Cell; 2018 Dec; 9(12):1004-1012. PubMed ID: 29497990
[TBL] [Abstract][Full Text] [Related]
3. Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupus-associated polymorphism FcγRIIB-T232.
Xu L; Xia M; Guo J; Sun X; Li H; Xu C; Gu X; Zhang H; Yi J; Fang Y; Xie H; Wang J; Shen Z; Xue B; Sun Y; Meckel T; Chen YH; Hu Z; Li Z; Xu C; Gong H; Liu W
J Exp Med; 2016 Nov; 213(12):2707-2727. PubMed ID: 27799621
[TBL] [Abstract][Full Text] [Related]
4. Role of lipid nanodomains for inhibitory FcγRIIb function.
Spiegel F; Trollmann MFW; Kara S; Pöhnl M; Brandner AF; Nimmerjahn F; Lux A; Böckmann RA
bioRxiv; 2023 May; ():. PubMed ID: 37214871
[TBL] [Abstract][Full Text] [Related]
5. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
Niederer HA; Clatworthy MR; Willcocks LC; Smith KG
Ann N Y Acad Sci; 2010 Jan; 1183():69-88. PubMed ID: 20146709
[
